Literature DB >> 25951122

Optimizing atrial fibrillation management: from ICU and beyond.

Allan J Walkey1, D Kyle Hogarth2, Gregory Y H Lip3.   

Abstract

Atrial fibrillation (AF) that newly occurs during critical illness presents challenges for both short- and long-term management. During critical illness, patients with new-onset AF are clinically evaluated for hemodynamic instability owing to the arrhythmia as well as for potentially reversible arrhythmia triggers. Hemodynamically significant AF that persists during critical illness may be treated with heart rate or rhythm control strategies. Recent evidence suggests that patients in whom AF develops during acute illness (eg, sepsis, postoperatively) have high long-term risks for AF recurrence and for AF-associated complications, such as stroke, heart failure, and death. Therefore, we suggest increased efforts to improve communication of AF events between inpatient and outpatient providers and to reassess patients who had experienced new-onset AF during critical illness after they transition to the post-ICU setting. We describe various strategies for the assessment and long-term management of patients with new-onset AF during critical illness.

Entities:  

Mesh:

Year:  2015        PMID: 25951122      PMCID: PMC4594627          DOI: 10.1378/chest.15-0358

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  45 in total

1.  Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study.

Authors:  C Martinez; A Katholing; S B Freedman
Journal:  Thromb Haemost       Date:  2014-06-18       Impact factor: 5.249

2.  Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.

Authors:  Robby Nieuwlaat; Alessandro Capucci; Gregory Y H Lip; S Bertil Olsson; Martin H Prins; Fred H Nieman; José López-Sendón; Panos E Vardas; Etienne Aliot; Massimo Santini; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2006-05-26       Impact factor: 29.983

3.  Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study.

Authors:  Bouwe P Krijthe; Jan Heeringa; Jan A Kors; Albert Hofman; Oscar H Franco; Jacqueline C M Witteman; Bruno H Stricker
Journal:  Int J Cardiol       Date:  2013-08-24       Impact factor: 4.164

4.  Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" prediction.

Authors:  Gregory Yh Lip; Deirdre A Lane
Journal:  Circ J       Date:  2014-07-08       Impact factor: 2.993

5.  Preventing cardiovascular complications of acute infection: a missed opportunity?

Authors:  Allan J Walkey
Journal:  Circulation       Date:  2014-02-12       Impact factor: 29.690

Review 6.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

7.  A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.

Authors:  Tatjana S Potpara; Marija M Polovina; Jelena M Marinkovic; Gregory Y H Lip
Journal:  Int J Cardiol       Date:  2013-08-01       Impact factor: 4.164

8.  Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.

Authors:  G Delle Karth; A Geppert; T Neunteufl; U Priglinger; M Haumer; M Gschwandtner; P Siostrzonek; G Heinz
Journal:  Crit Care Med       Date:  2001-06       Impact factor: 7.598

9.  Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation.

Authors:  Orhan Onalan; Eugene Crystal; Amin Daoulah; Ching Lau; Alexander Crystal; Ilan Lashevsky
Journal:  Am J Cardiol       Date:  2007-04-26       Impact factor: 2.778

10.  The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period.

Authors:  Daniel J Cushing; Warren D Cooper; Michael R Gralinski; Raymond J Lipicky
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-09-28       Impact factor: 2.557

View more
  20 in total

Review 1.  Atrial Fibrillation in the ICU.

Authors:  Nicholas A Bosch; Jonathan Cimini; Allan J Walkey
Journal:  Chest       Date:  2018-04-06       Impact factor: 9.410

2.  Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies.

Authors:  Yan-Guang Li; Marco Borgi; Gregory Yh Lip
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2018-10-24

Review 3.  [New onset atrial fibrillation in patients with sepsis].

Authors:  M Keller; R Meierhenrich
Journal:  Anaesthesist       Date:  2017-10       Impact factor: 1.041

4.  Non-antiarrhythmic interventions in new onset and paroxysmal sepsis-related atrial fibrillation.

Authors:  Antoine Vieillard-Baron; John Boyd
Journal:  Intensive Care Med       Date:  2017-11-07       Impact factor: 17.440

Review 5.  Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines.

Authors:  William F McIntyre; Jeff Healey
Journal:  J Atr Fibrillation       Date:  2017-04-30

6.  Prognostic impact of sustained new-onset atrial fibrillation in critically ill patients.

Authors:  Takuo Yoshida; Shigehiko Uchino; Yusuke Sasabuchi; Yasuhiro Hagiwara
Journal:  Intensive Care Med       Date:  2019-11-04       Impact factor: 17.440

7.  Initial Precipitants and Recurrence of Atrial Fibrillation.

Authors:  Elizabeth Y Wang; Olivia L Hulme; Shaan Khurshid; Lu-Chen Weng; Seung Hoan Choi; Allan J Walkey; Jeffrey M Ashburner; David D McManus; Daniel E Singer; Steven J Atlas; Emelia J Benjamin; Patrick T Ellinor; Ludovic Trinquart; Steven A Lubitz
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-02-12

8.  Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study.

Authors:  Laurent Fauchier; Nicolas Clementy; Arnaud Bisson; Karim Stamboul; Fabrice Ivanes; Denis Angoulvant; Dominique Babuty; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2016-09-30       Impact factor: 5.460

9.  Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation.

Authors:  Wen Cheng Liu; Wen Yu Lin; Chin Sheng Lin; Han Bin Huang; Tzu Chiao Lin; Shu Meng Cheng; Shih Ping Yang; Jung Chung Lin; Wei Shiang Lin
Journal:  Crit Care       Date:  2016-11-18       Impact factor: 9.097

Review 10.  Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit: a systematic scoping review.

Authors:  Laura Drikite; Jonathan P Bedford; Liam O'Bryan; Tatjana Petrinic; Kim Rajappan; James Doidge; David A Harrison; Kathryn M Rowan; Paul R Mouncey; Duncan Young; Peter J Watkinson; Mark Corbett
Journal:  Crit Care       Date:  2021-07-21       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.